Evidence map›Paper›PMID 32380565›Full record

ArticleAmerican journal of perinatology2020

COVID-19 in Newborns and Infants-Low Risk of Severe Disease: Silver Lining or Dark Cloud?

Munmun Rawat, Praveen Chandrasekharan, Mark D Hicar, Satyan Lakshminrusimha

Open access · bronzeAbstract read
In one paragraph

Article in American journal of perinatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 3 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 3 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Article
  5. Role of epinephrine in attenuating cytokine storm, decreasing ferritin, and inhibiting ferroptosis in SARS-CoV-2.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2024
    Article
  6. Causal associations and genetic overlap between COVID-19 and intelligence.QJM : monthly journal of the Association of Physicians · 2023
    Article
  7. Review
  8. COVID Encephalopathy in a Newborn.Indian journal of pediatrics · 2023
    Article
  9. Article
  10. Review
  11. Review
  12. Breastfeeding during the COVID-19 pandemic.Frontiers in pediatrics · 2023
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Munmun RawatDepartment of Pediatrics, University at Buffalo, Buffalo, New York.
Praveen ChandrasekharanDepartment of Pediatrics, University at Buffalo, Buffalo, New York.
Mark D HicarDepartment of Pediatrics, University at Buffalo, Buffalo, New York.
Satyan LakshminrusimhaDepartment of Pediatrics, University of California, Davis, California.
University at Buffalo, State University of New York · USUniversity of California, Davis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One hundred years after the 1918 influenza pandemic, we now face another pandemic with the severe acute respiratory syndrome-novel coronavirus-2 (SARS-CoV-2). There is considerable variability in the incidence of infection and severe disease following exposure to SARS-CoV-2. Data from China and the United States suggest a low prevalence of neonates, infants, and children, with those affected not suffering from severe disease. In this article, we speculate different theories why this novel agent is sparing neonates, infants, and young children. The low severity of SARS-CoV-2 infection in this population is associated with a high incidence of asymptomatic or mildly symptomatic infection making them efficient carriers. KEY POINTS: · There is a low prevalence of novel coronavirus disease in neonates, infants, and children.. · The fetal hemoglobin may play a protective role against coronavirus in neonates.. · Immature angiotensin converting enzyme (ACE2) interferes with coronavirus entry into the cells..

Indexed as

BetacoronavirusCoronavirus InfectionsPandemicsPneumonia, ViralAge of OnsetAngiotensin-Converting Enzyme 2Asymptomatic DiseasesChild, PreschoolCOVID-19Fetal HemoglobinHumansInfantInfant, NewbornPeptidyl-Dipeptidase APrevalenceProtective FactorsACE2 protein, humanAngiotensin-Converting Enzyme 2Fetal HemoglobinPeptidyl-Dipeptidase A

Identifiers

PMID32380565
PMCPMC7356082
OpenAlexW3022912727

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.